69 related articles for article (PubMed ID: 3506525)
1. Nucleologram variations in circulating lymphocytes after chemotherapy.
Malacarne P; Marzola M; Santini A; Nielsen I
Folia Biol (Praha); 1986; 32(5):349-53. PubMed ID: 3506525
[TBL] [Abstract][Full Text] [Related]
2. Effects of two different hydrocortisone doses on human peripheral blood lymphocyte nucleologram.
Malacarne P; Marzola M; Santini A; Indelli M
Folia Biol (Praha); 1989; 35(1):13-8. PubMed ID: 2714498
[TBL] [Abstract][Full Text] [Related]
3. [Importance of nucleolar lymphocyte changes during a course of malignant lympho-granuloma].
Dienstbier Z; Vĕtrovcová-Wienerová E; Foltýnová V
Cas Lek Cesk; 1976 Feb; 115(8):246-50. PubMed ID: 1253234
[No Abstract] [Full Text] [Related]
4. Morphological changes in the nucleoli of peripheral-blood lymphocytes as prognostic criteria in the chemotherapy of malignant tumors.
Matĕjoková E; Smetana K
Neoplasma; 1975; 22(3):303-12. PubMed ID: 1174261
[TBL] [Abstract][Full Text] [Related]
5. Nucleoli in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia treated with cytostatic drugs.
Kopeć J; Sitarska E; Leszko B
Arch Immunol Ther Exp (Warsz); 1983; 31(4):481-7. PubMed ID: 6670918
[TBL] [Abstract][Full Text] [Related]
6. Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients.
Staritz P; Kienle P; Koch M; Benner A; von Knebel Doeberitz M; Rudi J; Weitz J
J Exp Clin Cancer Res; 2004 Dec; 23(4):633-9. PubMed ID: 15743034
[TBL] [Abstract][Full Text] [Related]
7. Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology.
Lissoni P; Fumagalli L; Brivio F; Rovelli F; Messina G; Di Fede G; Colciago M; Brera G
J Biol Regul Homeost Agents; 2006; 20(1-2):29-35. PubMed ID: 18088552
[TBL] [Abstract][Full Text] [Related]
8. Qualitative and quantitative changes of nucleoli in lymphocytes of cancer patients during cytembena or cyclophosphamide therapy.
Matĕjková E; Vlastiborová A
Neoplasma; 1973 May; 20(5):517-23. PubMed ID: 4800661
[No Abstract] [Full Text] [Related]
9. Changes of the blood lymphocyte population in cancer patients treated with bestatin, a new immunomodulator. A phase I study.
Blomgren H; Strender LE; Edsmyr F
Biomedicine; 1980 Dec; 32(4):178-85. PubMed ID: 7470579
[TBL] [Abstract][Full Text] [Related]
10. Effects of feed restriction on the nucleolar structure and function in lymphocytes.
Berger J; Machackova M; Berger Z
Basic Clin Pharmacol Toxicol; 2005 Oct; 97(4):236-7. PubMed ID: 16176559
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy.
Mantovani G; Macciò A; Madeddu C; Mulas C; Massa E; Astara G; Ferreli L; Mudu MC; Gramignano G; Murgia V; Lusso MR; Mocci M; Cardia A; Mura L
Oncol Rep; 2002; 9(4):887-96. PubMed ID: 12066227
[TBL] [Abstract][Full Text] [Related]
12. Study of some lymphocyte metabolic parameters in diabetes mellitus.
Cheţa D; Cheţa N; Mihalache N; Micu D; Ionescu-Tîrgovişte C; Mihăilescu E; Mincu I
Med Interne; 1982; 20(1):25-32. PubMed ID: 6086031
[TBL] [Abstract][Full Text] [Related]
13. Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.
De Santis S; Pace A; Bove L; Cognetti F; Properzi F; Fiore M; Triaca V; Savarese A; Simone MD; Jandolo B; Manzione L; Aloe L
Clin Cancer Res; 2000 Jan; 6(1):90-5. PubMed ID: 10656436
[TBL] [Abstract][Full Text] [Related]
14. PHA responsiveness and adherent cell-lymphocyte interactions in patients with advanced malignant tumors of the ovary prior to treatment and during chemotherapy.
Markowska J; Jaroszewski J; Jankowiak S; Wiktorowicz K; Jaskulska T
Neoplasma; 1986; 33(3):361-9. PubMed ID: 3736722
[TBL] [Abstract][Full Text] [Related]
15. Outpatient cancer drug costs: changes, drivers, and the future.
Halbert RJ; Zaher C; Wade S; Malin J; Lawless GD; Dubois RW
Cancer; 2002 Feb; 94(4):1142-50. PubMed ID: 11920485
[TBL] [Abstract][Full Text] [Related]
16. Cancer chemotherapy induces a transient increase of serum-iron level.
Follézou JY; Bizon M
Neoplasma; 1986; 33(2):225-31. PubMed ID: 3713925
[TBL] [Abstract][Full Text] [Related]
17. [The nucleolar apparatus of the lymphocytes in the peripheral blood of subjects with a history of infectious mononucleosis].
Modestova EV
Lab Delo; 1988; (10):41-2. PubMed ID: 2462087
[No Abstract] [Full Text] [Related]
18. Cytogenetic outcomes of adjuvant chemotherapy in non-target cells of breast cancer patients.
Kopjar N; Milas I; Garaj-Vrhovac V; Gamulin M
Hum Exp Toxicol; 2007 May; 26(5):391-9. PubMed ID: 17623763
[TBL] [Abstract][Full Text] [Related]
19. Nucleoli of peripheral blood lymphocytes in patients with chronic lymphocytic leukemia.
Kopeć J; Sitarska E; Leszko B
Arch Immunol Ther Exp (Warsz); 1980; 28(5):685-90. PubMed ID: 6163415
[TBL] [Abstract][Full Text] [Related]
20. Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4+ cell proliferation.
Sara E; Kotsakis A; Souklakos J; Kourousis C; Kakolyris S; Mavromanolakis E; Vlachonicolis J; Georgoulias V
Anticancer Res; 1999; 19(1A):471-6. PubMed ID: 10226584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
